2024
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, A... |
|
P/S
|
Providing medical information; providing medical information in the field of Alzheimer's. |
|
P/S
|
Medical information services, namely providing information related to healthcare and diseases and... |
|
P/S
|
Downloadable software in the nature of a mobile application for providing healthcare-related info... |
|
P/S
|
Educational services on the topic of medical matters; arranging and conducting educational forums... |
|
P/S
|
Medical information services in the field of pharmaceuticals and clinical trials; providing data ... |
|
P/S
|
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention an... |
|
P/S
|
Scientific research and development; Scientific laboratory services, namely, providing shared wet... |
|
P/S
|
Providing medical information; providing medical information in the field of Alzheimer's |
|
P/S
|
Near field communication (NFC) tags for the purpose of tracking and authenticating pharmaceutical... |
|
P/S
|
Medical information services in the field of diabetes, endocrine diseases and disorders, metaboli... |
|
P/S
|
Medical information services in the field of diabetes, obesity, overweight and metabolic disease;... |
|
P/S
|
Printed reports featuring laboratory, clinical and diagnostic testing and results; printed inform... |
|
P/S
|
Medical information services in the field of diabetes |
|
P/S
|
Providing medical and scientific research information including in the field of Alzheimer's and r... |
|
P/S
|
Providing medical and scientific research information in the field of Alzheimer's and related dis... |
|
P/S
|
Educational services, namely, programs for healthcare personnel about clinical cases and communic... |
2023
|
Invention
|
Medication delivery device including disposable and reusable portions.
A medication delivery dev... |
|
Invention
|
Medication delivery device with a sensed element.
A medication delivery device including a devic... |
|
Invention
|
Kcnq potentiators.
Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—... |
|
Invention
|
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-pipe... |
|
Invention
|
Methods for producing fabs and igg bispecific antibodies.
Methods for producing Fabs and IgG bi-... |
|
Invention
|
Anti-human lair1 antibodies. The present disclosure relates to antibodies that bind human LAIR1 (... |
|
Invention
|
Treatment and prevention of diseases. Methods of modulating expression and / or secretion of at l... |
|
Invention
|
Systems and methods for detecting state of a medication delivery device. A sensing system for det... |
|
Invention
|
Gip and glp-1 dual agonist compounds. The present invention relates to a pharmaceutical compositi... |
|
Invention
|
A gip/glp1 for use in therapy. The present invention provides a method for improving glycemic con... |
|
Invention
|
Glucocorticoid receptor agonists.
The present invention provides a compound of Formula I:
The ... |
|
Invention
|
Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives as fgfr3 inhibitors for the treatm... |
|
Invention
|
Co-crystals of 4-[4-[3-chloro-4-[1-(2-pyridyl)-2-hydroxy-ethoxy]pyrazolo[1,5-a]pyridin-6-yl]-5-me... |
|
Invention
|
Infusion site failure detection. Systems, methods, and devices are provided for predicting a stat... |
|
Invention
|
Compositions for oral delivery. The present invention relates to a dosage form suitable for oral ... |
|
Invention
|
Pd-1 agonist antibodies and methods of treating autoimmune diseases with a pd-1 agonist antibody.... |
|
Invention
|
Sstr4 agonist salts.
The present invention relates to specific salts of (1S,5R)-(1α,5α,6α)-N-[1,... |
|
Invention
|
Transferrin receptor binding proteins and conjugates.
Provided herein are proteins comprising on... |
|
Invention
|
Transferrin receptor binding proteins and conjugates. Provided herein are proteins comprising one... |
|
Invention
|
Pharmaceutical solutions of anti-n3pglu aβ antibodies and uses thereof. The present disclosure re... |
|
Invention
|
Kras g12c inhibitor for treating cancer. Disclosed herein are dosing regimens for the administrat... |
|
Invention
|
Tirzepatide compositions and use. A composition and methods of dosing such tirzepatide compositio... |
|
Invention
|
Human cd33 antibodies and glucocorticoid conjugates. The present disclosure provides human CD33 a... |
|
Invention
|
Atxn2 rna interference agents. Provided herein are ATXN2 RNAi agents and compositions comprising ... |
|
Invention
|
Fluid delivery cassette. A fluid delivery cassette includes a cartridge assembly and a needle ass... |
|
Invention
|
Cgas inhibitors.
The present invention relates to novel cGAS inhibitor compounds, to pharmaceuti... |
|
Invention
|
Cgas inhibitors. The present invention relates to novel cGAS inhibitor compounds, to pharmaceutic... |
|
Invention
|
Methods of using a gcg/glp1 co-agonist for therapy. Doses and dosing regimens for incretin analog... |
|
Invention
|
Human interleukin-4 receptor alpha antibody glucocorticoid conjugates. The present disclosure pro... |
|
Invention
|
Lasofoxifene combination treatment of er+ breast cancer that has progressed on a cdk4/6 inhibitor... |
|
Invention
|
Continuous tangential flow filtration system. Tangential flow filtration systems and, more specif... |
|
Invention
|
Human tumor necrosis factor alpha antibody glucocorticoid conjugates.
The present disclosure pro... |
|
Invention
|
Kras inhibitors.
The present invention provides compounds of the formula:
The present inventio... |
2022
|
Invention
|
Techniques for processing wirelessly broadcast packets from a medical device with dose-related da... |
|
Invention
|
Automatic injection device |
|
Invention
|
Status sensing systems for connected injection device.
Drug-delivery systems configured to gener... |
|
Invention
|
Oxyntomodulin binding molecules, and uses thereof.
Provided herein are novel N- and C-terminal o... |
|
Invention
|
Anti-n3pglu amyloid beta antibodies and uses thereof.
The invention is directed to treatment or ... |
|
Invention
|
Hub for reusable drug-delivery device.
A recharging and medication storage hub for a re-usable d... |
2021
|
Invention
|
Pretargeting imaging agents.
The present invention provides novel compounds:
The present inven... |
|
Invention
|
Methods of treating diabetes.
Described herein are fixed doses and dosing regimens for long-acti... |
|
Invention
|
Methods of treating diabetes.
Described herein are doses and dosing regimens comprising determin... |
|
Invention
|
Fluid delivery system with needle assembly.
A needle assembly configured to be part of a drug de... |
|
Invention
|
Kras g12c inhibitors.
The present disclosure provides compounds of the formula:
The present di... |
|
Invention
|
Medication delivery device with moisture sensing system.
Medication delivery devices are provide... |
|
Invention
|
Methods for reducing host cell protein content in antibody purification processes and antibody co... |
|
Invention
|
Devices and processes for delivery of therapeutic fluids.
A therapeutic agent delivery system in... |
2020
|
Invention
|
Medication delivery device with needle carrier.
Drug delivery devices are provided having a need... |